Bain Capital Life Sciences Investors
$1.1B Assets Reported
22 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| HTFL | HEARTFLOW INC | 10,448,158 | $254M | 22.9% |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 7,306,566 | $234M | 21.1% |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,473,238 | $111M | 10.0% |
| SVRA | SAVARA INC | 17,600,621 | $96M | 8.7% |
| PHVS | PHARVARIS N V | 2,675,509 | $76M | 6.8% |
| SLDB | SOLID BIOSCIENCES INC | 9,808,819 | $71M | 6.4% |
| XFOR | X4 PHARMACEUTICALS INC | 7,967,454 | $33M | 3.0% |
| DNTH | DIANTHUS THERAPEUTICS INC | 362,470 | $30M | 2.7% |
| ANNX | ANNEXON INC | 5,212,674 | $29M | 2.6% |
| KYTX | KYVERNA THERAPEUTICS INC | 3,110,000 | $27M | 2.4% |
Track Bain Capital Life Sciences Investors's 13F portfolio: $1.1B in reported holdings, 22 positions. Top holdings, AUM, and quarterly changes on SentiSense.